Grane Rx is poised to take a leading role in promoting patient safety through precision medicine. YouScript and Grane Rx announce today an agreement to deliver precision prescribing support to post-acute care organizations. Adverse drug events (ADEs) are a leading cause of avoidable hospitalization among the senior population. Each year, these events claim more than 100,000 lives and cause more … Read More
YouScript and PDX Join Together to Reduce Adverse Drug Events by Bringing Precision Medicine to Community Pharmacies
YouScript and PDX announce today an agreement to deliver integrated YouScript® precision prescribing clinical decision support to all PDX pharmacy software users that opt in. Pharmacists will now be able to advise patients when they have a high risk of gene-based adverse drug events, and work with their providers to order testing and optimize drug and dose selection based on … Read More
YouScript Now a Verified Company with HealthXL
YouScript, a life-saving clinical decision support tool, aiding enterprise health solution providers in reducing the adverse drug event epidemic. Seattle, WA — (July 26, 2017) — YouScript is now a verified company with HealthXL , a global organization driving innovation in healthcare through an elite network of healthcare executives and global solutions. Companies can only obtain verified status when there … Read More
Gauging the Impact of Disruptive Innovation
Disruptive innovation refers to an innovation that creates a new market and value network and eventually disrupts an existing market and value network, displacing established market leading firms, products, and alliances.1 Consider this — when digital cameras were new, was the leading film company innovating in this digital space? With a large shift in how consumers capture, share, and store … Read More
YouScript at the Long Term Post Acute Care & HIT Summit
YouScript CEO Kristine Ashcraft attended the Long Term Post Acute Care & HIT Summit this week in Baltimore, MD to present a talk on the implications of pharmacogenetic testing, polypharmacy, and its impact on the elderly. The presentation Kristine gave was titled “Integration and Outcomes: Shifting Precision Medicine from the Future to Now” Many in healthcare today consider precision medicine … Read More
This Month in Pharmacogenetics and HealthIT – February 2017
Pharmacogenomics and Precision Medicine is trending like never before, with the strides that are being made in this field. While you can go and search out the news yourself, we want to make it easy for you. You can start by following social media platforms: Facebook, Twitter, Pinterest, and LinkedIn. We’re constantly posting relevant articles from around the web. Or … Read More
YouScript and Elsevier Collaborating to Incorporate Gene-based Prescribing and Reduce Alert Fatigue
Seattle, WA – YouScript and Elsevier are collaborating to bring individualized, relevant drug and dose optimization guidance to providers, pharmacists and patients wherever medication decisions are made. On February 2, 2017, Harding University published a randomized controlled trial in PLOS One in high-risk polypharmacy patients to incorporate pharmacogenetic data and YouScript’s clinical decision support system and compare results to a … Read More
YouScript.net Release Notes 2-13-2017
Welcome to the new and improved YouScript Precision Prescribing Software. We have made a number of quality of life changes and improvements to the software, check out the changes below. You may have to refresh your browser to ensure all the changes are available. Log in to YouScript. NEW: Complete makeover of our User Interface to reflect our new logo. … Read More
New Precision Medicine Study Confirms Dramatic Reduction in Readmissions and ER Visits
Use of pharmacogenetic testing supported by an appropriate clinical decision support tool reduces mortality and overall health resource utilization in patients treated with multiple medications Seattle, WA — YouScript, a proprietary clinical decision support tool designed to assist in medication therapy management, has been shown to reduce readmissions by 52 percent (p=0.007) and ER visits by 42 percent (p=0.045) in … Read More